Bioanalytical Systems Inc (NASDAQ:BASI)

2.07
Delayed Data
As of Apr 17
 0.00 / 0.00%
Today’s Change
1.85
Today|||52-Week Range
2.87
-5.03%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$16.7M

Company Description

Bioanalytical Systems, Inc. operates as a pharmaceutical development company which provides drug discovery, development services and analytical instruments. It supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The company operates through two business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. Bioanalytical Systems was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Contact Information

Bioanalytical Systems, Inc.
Purdue Research Park
West Lafayette Indiana 47906-1382
P:(765) 463-4527
Investor Relations:

Employees

Shareholders

Other institutional5.13%
Mutual fund holders4.30%
Individual stakeholders22.95%

Top Executives

Jacqueline M. LemkePresident, Chief Executive Officer & Director
James Sevall BourdageVice President-Operations
Jeffrey PotrzebowskiChief Financial Officer & Vice President
Philip A. DowningVice President-Preclinical Services
Connie Dougherty LeighVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account